Related Experiment Videos
Antigen-specific therapies in multiple sclerosis
1Division of Immunological and Infectious Diseases, TNO Prevention and Health, Leiden, The Netherlands. jm.vannoort@pg.tno.nl
Biotherapy (Dordrecht, Netherlands)
|April 29, 1998
Summary
Multiple sclerosis (MS) involves inflammatory brain lesions that damage myelin and impair nerve signals. Current research focuses on blocking myelin-reactive T-cells to control this neurological disease.
Area of Science:
- Neuroimmunology
- Neurology
Background:
- Multiple sclerosis (MS) is a leading neurological disorder in young adults, impacting approximately 1 in 1,000 individuals.
- MS is characterized by inflammatory lesions in the central nervous system's white matter, leading to myelin sheath damage and impaired axonal conductivity.
- The disease process is believed to initiate with the activation of helper T cells targeting local myelin antigens.
Purpose of the Study:
- To discuss the immunological aspects of multiple sclerosis.
- To review the experimental allergic encephalomyelitis (EAE) model for MS.
- To explore myelin antigens implicated in MS and strategies for blocking T-cell activation.
Main Methods:
- Review of immunological features of multiple sclerosis.
- Discussion of the experimental allergic encephalomyelitis model.
- Overview of potential myelin target antigens in MS.
- Analysis of current therapeutic strategies targeting T-cell activation.
Main Results:
- The chapter details the immunological underpinnings of MS.
- It highlights the role of myelin antigens and T-cell responses.
- Experimental allergic encephalomyelitis serves as a key model for understanding disease mechanisms.
Conclusions:
- Understanding MS immunology is crucial for developing effective treatments.
- Targeting myelin-reactive T cells offers a promising therapeutic avenue.
- Further research into myelin antigens and T-cell modulation is essential for MS management.